AzTrials
AzTrials

Appendectomy, LaparoscopicL-TAPNCT07921862

Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy

A study testing Bupivacaine (Transversus Abdominis Plane Block) in people with Appendectomy, Laparoscopic and Blockades Neuromuscular, run by Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Appendectomy is one of the most frequently performed surgical procedures worldwide and remains the gold standard treatment for acute appendicitis. Although laparoscopic surgery offers advantages such as less pain, faster recovery, and shorter hospital stays compared to open techniques, postoperative pain caused by… Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Bupivacaine (Transversus Abdominis Plane Block)
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2026to 30 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged between 18 and 65 years
  • Patients undergoing uncomplicated laparoscopic appendectomy
  • Patients with American Society of Anesthesiologists physical status I-III

Who cannot join

  • Presence of appendiceal perforation or complicated appendicitis (such as abscess or peritonitis)
  • Anatomical abnormalities or deformities of the anterior abdominal wall
  • Known hypersensitivity or allergy to local anesthetics (such as bupivacaine or amide-type local anesthetics)
  • Morbid obesity, defined as a Body Mass Index greater than 40 kg/m²
  • History of opioid, alcohol, or substance abuse or dependence
  • Active or severe psychiatric illness that may interfere with the study protocol
Show all 14Show fewer
  • Inability to communicate in the local language or requiring an interpreter
  • Known coagulation disorders, bleeding diathesis, or active anticoagulant therapy
  • Total body weight less than 50 kg
  • History of cardiac arrhythmia or severe cardiac conduction defects
  • Pre-existing neurological deficits or peripheral neuropathy at the procedure or injection site
  • Cognitive impairment, inability to understand the study procedures, or inability to appropriately respond to questionnaires
  • Pregnancy or lactation
  • History of major abdominal surgery that may alter the abdominal wall anatomy or laparoscopic visibility

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Erzincan İl Sağlik Müdürlüğü Binali Yildirim Üniversitesi Mengücek Gazi Eğitim Ve Araştirma Hastanesi

    Erzincan, Merkez, 24100

Other trials in Turkey (Türkiye)

About this study

Official title: Efficacy of Laparoscopic-Assisted Transversus Abdominis Plane Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Appendectomy: A Randomized Controlled Trial

Appendectomy is one of the most frequently performed surgical procedures worldwide and remains the gold standard treatment for acute appendicitis. Although laparoscopic surgery offers advantages such as less pain, faster recovery, and shorter hospital stays compared to open techniques, postoperative pain caused by visceral stimulation from pneumoperitoneum and tissue trauma is still inevitable. Inadequate analgesia delays the recovery process, whereas high-dose opioid use leads to complications such as nausea, vomiting, and respiratory depression. Therefore, within the framework of Enhanced Recovery After Surgery (ERAS) protocols, multimodal analgesia methods and interfacial plane blocks that reduce opioid consumption have gained prominence. The Transversus Abdominis Plane (TAP) block is an effective regional anesthesia technique where a local anesthetic is injected into the fascial plane between the internal oblique and transversus abdominis muscles. Initially described using anatomical landmarks, this method has become widely used with the addition of ultrasound guidance. The TAP block features different modalities, including subcostal, lateral, posterior, dual, and surgeon-performed laparoscopic-assisted approaches. While the subcostal approach targets the supraumbilical (T7-9) region, the lateral and posterior approaches block the infraumbilical (T10-L1) nerve branches. In recent years, the transperitoneal approach, performed by the surgeon under direct vision during laparoscopic surgery, has gained popularity. This technique is performed by advancing the needle through the parietal peritoneum into the transversus abdominis muscle. Due to direct visualization, the risk of visceral injury decreases, and the success rate of delivering the drug to the correct fascial plane increases. This study aims to evaluate and compare the efficacy of surgeon-performed laparoscopic-assisted transversus abdominis plane block versus standard intravenous analgesia in patients undergoing laparoscopic appendectomy.

Read the detailed description

Laparoscopic appendectomy is the most frequently performed surgical procedure for patients presenting with acute appendicitis. Compared to open appendectomy, this technique offers significant advantages, including a lower risk of complications, reduced postoperative pain, and a faster return to daily activities. Although the laparoscopic technique is minimally invasive, postoperative pain remains inevitable. This discomfort can restrict patient mobility and prolong the duration of hospital stay. The Transversus Abdominis Plane (TAP) block is a regional anesthesia procedure involving the injection of a local anesthetic solution into the TAP zone of the abdominal wall. Recently, this procedure has gained widespread popularity for its efficacy in reducing both postoperative pain and opioid analgesic requirements after various abdominal surgeries. The TAP block has been widely utilized in numerous operations, including colorectal surgery, upper gastrointestinal surgeries, cholecystectomy, appendectomy, hysterectomy, and prostatectomy. Various approaches exist for its clinical application. It has been reported that ultrasound-guided TAP block significantly reduces pain in patients following laparoscopic appendectomy. Similarly, literature demonstrates that this method shortens the length of stay in the post-anesthesia care unit (PACU) and decreases intraoperative analgesic requirements in patients undergoing laparoscopic appendectomy. Regarding the laparoscopically-assisted approach, studies state that laparoscopic TAP (LTAP) block provides a significant reduction in pain scores up to 24 hours postoperatively, as well as lower rates of postoperative nausea and vomiting (PONV). The analgesic efficacy of LTAP was also emphasized by findings showing that this method ensures effective pain control at abdominal incision sites, reduces narcotic consumption, and shortens the hospital stay after laparoscopic colorectal surgery. On the other hand, it is noted that there is still no clear consensus in the literature regarding whether the TAP block is the most effective option for pain management after laparoscopic appendectomy. Due to the lack of definitive and conclusive results in the literature regarding the LTAP block in laparoscopic appendectomy patients, this study aims to evaluate and compare the postoperative analgesic requirements, efficacy, and safety of the LTAP block versus standard intravenous analgesia.

Being tested
Bupivacaine (Transversus Abdominis Plane Block)
Keywords
TRANSVERSUS ABDOMINIS PLANE BLOCK, LAPAROSCOPIC-ASSISTED

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bupivacaine (Transversus Abdominis Plane Block)Drug

    Also called LTAP

    At the end of the operation, a bilateral laparoscopic-assisted transversus abdominis plane (LTAP) block will be performed by the attending surgeon under direct laparoscopic visualization. Under sterile conditions, the facial plane between the internal oblique and transversus abdominis muscles will be accessed at the level of the mid-axillary line using a Braun Stimuplex A insulated needle. The correct placement will be confirmed by feeling the facial transition (two distinct "pop" sensations) and visualizing the inward pushing of the peritoneum (Doyle's internal bulge sign). Following negative aspiration to prevent intravascular injection, a total of 20 mL of 0.25% bupivacaine (Marcaine) will be administered as a 10 mL injection to each side (bilateral) into the fascial plane.

Study groups in NCT07921862
Study groupRoleWhat they receive
LTAPExperimentalAt the end of the operation, a bilateral laparoscopic-assisted transversus abdominis plane (LTAP) block will be performed by the attending surgeon under direct laparoscopic visualization.
Receives: Drug: Bupivacaine (Transversus Abdominis Plane Block)
STANDARD ANALGESIA GROUPNo interventionSTANDARD ANALGESIA GROUP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain Scores Assessed by the Visual Analog Scale

    Postoperative pain severity will be evaluated using the Visual Analog Scale. The scale ranges from a minimum value of 0, representing no pain, to a maximum value of 10, representing the worst possible pain. Higher scores mean a worse outcome, indicating more severe pain.

    Measured: Postoperative 2nd, 4th, 8th, 12th, and 24th hours

  2. Total Postoperative Analgesic Consumption in Milligrams

    The total cumulative dose of intravenous analgesic agents (such as tramadol, paracetamol, or opioids) administered to the patient as rescue analgesia within the first 24 hours after surgery. The total amount will be calculated and recorded in milligrams (mg). Higher cumulative values mean a worse outcome, indicating a greater requirement for pain medication.

    Measured: First 24 hours postoperatively

Secondary outcomes (4)
  1. Total Tramadol Consumption

    The total cumulative administration of intravenous or oral tramadol provided to the patient as analgesia within the specified postoperative timeframe. The consumption data is documented to assess pain management requirements following the surgical procedure.

    Measured: First 24 hours postoperatively

  2. Incidence of Postoperative Nausea and Vomiting

    The occurrence of postoperative nausea and vomiting (PONV) episodes will be monitored and documented during the first 24 hours after the surgical procedure. This outcome will be recorded as a percentage of patients experiencing symptoms within each study group. Higher percentages mean a worse outcome, indicating a higher rate of postoperative complications.

    Measured: Up to 24 hours postoperatively

  3. Time to First Flatus or Defecation in Hours

    The time elapsed from the end of the surgery until the first postoperative passage of flatus or defecation, measured in hours. This parameter is used to objectively evaluate gastrointestinal motility recovery. A shorter time frame indicates a better outcome, representing earlier return of bowel function.

    Measured: Up to hospital discharge (approximately 48 hours)

  4. Postoperative Sleep Quality

    Assessment of the patient's subjective sleep quality during the first postoperative night (e.g., using a numerical rating scale or questionnaire).

    Measured: Postoperative 24 hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2026
  2. Study start1 Aug 2026
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion30 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will be conducted among volunteers who present to the General Surgery Clinic at Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital, are diagnosed with acute appendicitis, and are scheduled to undergo laparoscopic appendectomy.
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
88 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07921862
Sponsor's protocol ID
MengucekGaziTRH
Other IDs
MengucekGaziTRH
Acronym
L-TAP
Status last verified
Nov 2026
First submitted
26 Sep 2026
Last updated
6 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Bupivacaine (Transversus Abdominis Plane Block) in people with Appendectomy, Laparoscopic and Blockades Neuromuscular, run by Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain Scores Assessed by the Visual Analog Scale (time frame: Postoperative 2nd, 4th, 8th, 12th, and 24th hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in